These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 1962275)

  • 41. Treatment with radiopharmaceutical drugs.
    McDougall IR
    Ration Drug Ther; 1978 Jan; 12(1):1-7. PubMed ID: 628766
    [No Abstract]   [Full Text] [Related]  

  • 42. [Radioisotope teletherapy of polycythemia vera].
    Belugina ZT; Kozyrina ZN; Komarova RS
    Med Radiol (Mosk); 1976; 21(9):84-6. PubMed ID: 1004152
    [No Abstract]   [Full Text] [Related]  

  • 43. [Radionuclide therapy--a possible way toward an improved treatment of cancer. The obstacle is the shortage of commercially available radionuclides for clinical use].
    Lundqvist H; Carlsson J; Gedda L; Tolmachev V; Garske U; Kairemo K
    Lakartidningen; 2004 Mar; 101(11):1000-2, 1005-6. PubMed ID: 15055121
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Systemic radiation therapy with unsealed radionuclides.
    McDougall IR
    Semin Radiat Oncol; 2000 Apr; 10(2):94-102. PubMed ID: 10727598
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Radionuclides linked to a CD74 antibody as therapeutic agents for B-cell lymphoma: comparison of Auger electron emitters with beta-particle emitters.
    Govindan SV; Goldenberg DM; Elsamra SE; Griffiths GL; Ong GL; Brechbiel MW; Burton J; Sgouros G; Mattes MJ
    J Nucl Med; 2000 Dec; 41(12):2089-97. PubMed ID: 11138697
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Radiolabeled monoclonal anti-tumor antibodies in diagnosis and therapy.
    Larson SM
    J Nucl Med; 1985 May; 26(5):538-45. PubMed ID: 3989608
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols.
    Berk PD; Goldberg JD; Donovan PB; Fruchtman SM; Berlin NI; Wasserman LR
    Semin Hematol; 1986 Apr; 23(2):132-43. PubMed ID: 3704665
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Boron neutron capture a a new radiotherapy model].
    Hideghéty K; Sauerwwein W; Rassuw J; Sack H
    Orv Hetil; 1998 Mar; 139(12):675-9. PubMed ID: 9555163
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Variables influencing tumor dosimetry in radioimmunotherapy of CEA-expressing cancers with anti-CEA and antimucin monoclonal antibodies.
    Behr TM; Sharkey RM; Juweid ME; Dunn RM; Ying Z; Zhang CH; Siegel JA; Goldenberg DM
    J Nucl Med; 1997 Mar; 38(3):409-18. PubMed ID: 9074529
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Imaging and therapy of cancer with radiolabeled monoclonal antibodies.
    Goldenberg DM
    Prog Clin Biol Res; 1989; 288():413-27. PubMed ID: 2654957
    [No Abstract]   [Full Text] [Related]  

  • 51. Options to meet the future global demand of radionuclides for radionuclide therapy.
    Das T; Pillai MR
    Nucl Med Biol; 2013 Jan; 40(1):23-32. PubMed ID: 23116551
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Requirements for a treatment planning system for radioimmunotherapy.
    DeNardo GL; Raventos A; Hines HH; Scheibe PO; Macey DJ; Hays MT; DeNardo SJ
    Int J Radiat Oncol Biol Phys; 1985 Feb; 11(2):335-48. PubMed ID: 3882643
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Radionuclide therapy revisited.
    Hoefnagel CA
    Eur J Nucl Med; 1991; 18(6):408-31. PubMed ID: 1879447
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Percutaneous radiotherapy of malignant tumors of the thyroid (author's transl)].
    Scherer E
    Rontgenblatter; 1975 Dec; 28(12):580-6. PubMed ID: 814608
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Options for radionuclide therapy: from fixed activity to patient-specific treatment planning.
    Thomas SR
    Cancer Biother Radiopharm; 2002 Feb; 17(1):71-82. PubMed ID: 11915175
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antibody-radionuclide conjugates for cancer therapy: historical considerations and new trends.
    Steiner M; Neri D
    Clin Cancer Res; 2011 Oct; 17(20):6406-16. PubMed ID: 22003068
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Radiation-induced biologic bystander effect elicited in vitro by targeted radiopharmaceuticals labeled with alpha-, beta-, and auger electron-emitting radionuclides.
    Boyd M; Ross SC; Dorrens J; Fullerton NE; Tan KW; Zalutsky MR; Mairs RJ
    J Nucl Med; 2006 Jun; 47(6):1007-15. PubMed ID: 16741311
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Miniature thermoluminescent dosimeter absorbed dose measurements in tumor phantom models.
    Wessels BW; Griffith MH
    J Nucl Med; 1986 Aug; 27(8):1308-14. PubMed ID: 3734904
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Radioisotopes in clinical practice.
    Croft DN; Williams O
    Br J Clin Pract; 1969 Dec; 23(12):493-500. PubMed ID: 4188051
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.